Device
Focused extracorporeal shock wave therapy
Total Trials
3
Max Phase
—
Type
DEVICE
Molecule
—
Success Metrics
Active Trials
0(0%)
Phase Distribution
Ph phase_2
1
33%
Ph not_applicable
2
67%
Phase Distribution
0
Early Stage
1
Mid Stage
0
Late Stage
Phase Distribution3 total trials
Phase 2Efficacy & side effects
1(33.3%)
N/ANon-phased studies
2(66.7%)
Highest Phase Reached
Phase 2Trial Status & Enrollment
Completion Rate
0.0%
0 of 0 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
0
trials recruiting
Total Trials
3
all time
Status Distribution
Active(1)
Other(2)
Detailed Status
unknown2
Not yet recruiting1
Development Timeline
Analytics
Development Status
Total Trials
3
Active
0
Success Rate
N/A
Most Advanced
Phase 2
Trials by Phase
Phase 21 (33.3%)
N/A2 (66.7%)
Trials by Status
not_yet_recruiting133%
unknown267%
Recent Activity
0 active trials
Showing 3 of 3
not_yet_recruitingnot_applicable
A Single-Blind Randomized Controlled Study Comparing the Efficacy of High-Intensity Laser Therapy and Focused Extracorporeal Shock Wave Therapy in Patients With Plantar Fasciitis
NCT07287046
unknownnot_applicable
Effectiveness of fESWT in the Treatment of CTS
NCT04302909
unknownphase_2
TENDOSHOCK-2010 Combination Therapy for Athletic Tendinopathies
NCT01185951
Clinical Trials (3)
Showing 3 of 3 trials
NCT07287046Not Applicable
A Single-Blind Randomized Controlled Study Comparing the Efficacy of High-Intensity Laser Therapy and Focused Extracorporeal Shock Wave Therapy in Patients With Plantar Fasciitis
NCT04302909Not Applicable
Effectiveness of fESWT in the Treatment of CTS
NCT01185951Phase 2
TENDOSHOCK-2010 Combination Therapy for Athletic Tendinopathies
All 3 trials loaded
Drug Details
- Intervention Type
- DEVICE
- Total Trials
- 3